Endo USA, Inc. recalls Clonazepam Orally Disintegrating Tablets
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
- Products
-
- Clonazepam Orally Disintegrating Tablets
- Company
- Endo USA, Inc.
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 8,029 cartons
- About this recall
- Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards containing 6 tablets each), Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-306-02 (carton), NDC #: 49884-306-52 (blisters).